115 related articles for article (PubMed ID: 9741997)
21. Dopamine D(1) receptor-mediated control of striatal acetylcholine release by endogenous dopamine.
Acquas E; Di Chiara G
Eur J Pharmacol; 1999 Oct; 383(2):121-7. PubMed ID: 10585525
[TBL] [Abstract][Full Text] [Related]
22. Effects of the dopamine D3 antagonist PD 58491 and its interaction with the dopamine D3 agonist PD 128907 on brain dopamine synthesis in rat.
Whetzel SZ; Shih YH; Georgic LM; Akunne HC; Pugsley TA
J Neurochem; 1997 Dec; 69(6):2363-8. PubMed ID: 9375667
[TBL] [Abstract][Full Text] [Related]
23. Ontogeny of the motor inhibitory role of dopamine D(3) receptor subtype in rats.
Heijtz RD; Ogren SO; Fuxe K
Eur J Pharmacol; 2000 Mar; 392(1-2):35-9. PubMed ID: 10748270
[TBL] [Abstract][Full Text] [Related]
24. S32504, a novel naphtoxazine agonist at dopamine D3/D2 receptors: I. Cellular, electrophysiological, and neurochemical profile in comparison with ropinirole.
Millan MJ; Cussac D; Gobert A; Lejeune F; Rivet JM; Mannoury La Cour C; Newman-Tancredi A; Peglion JL
J Pharmacol Exp Ther; 2004 Jun; 309(3):903-20. PubMed ID: 14978194
[TBL] [Abstract][Full Text] [Related]
25. Partial agonistic action of clozapine at dopamine D2 receptors in dopamine depleted animals.
Ninan I; Kulkarni SK
Psychopharmacology (Berl); 1998 Feb; 135(3):311-7. PubMed ID: 9498736
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and dopamine agonist properties of (+-)-trans-3,4,4a,10b-tetrahydro-4-propyl-2H,5H-[1]benzopyrano [4,3-b]-1,4-oxazin-9-ol and its enantiomers.
DeWald HA; Heffner TG; Jaen JC; Lustgarten DM; McPhail AT; Meltzer LT; Pugsley TA; Wise LD
J Med Chem; 1990 Jan; 33(1):445-50. PubMed ID: 1967318
[TBL] [Abstract][Full Text] [Related]
27. Characterization of the effect of dopamine D3 receptor stimulation on locomotion and striatal dopamine levels.
De Boer P; Enrico P; Wright J; Wise LD; Timmerman W; Moor E; Dijkstra D; Wikström HV; Westerink BH
Brain Res; 1997 May; 758(1-2):83-91. PubMed ID: 9203536
[TBL] [Abstract][Full Text] [Related]
28. The behavioural effects of pramipexole, a novel dopamine receptor agonist.
Maj J; Rogóz Z; Skuza G; Kołodziejczyk K
Eur J Pharmacol; 1997 Apr; 324(1):31-7. PubMed ID: 9137910
[TBL] [Abstract][Full Text] [Related]
29. Dopamine D3 receptor agonists partially reproduce the discriminative stimulus effects of cocaine in squirrel monkeys.
Spealman RD
J Pharmacol Exp Ther; 1996 Sep; 278(3):1128-37. PubMed ID: 8819495
[TBL] [Abstract][Full Text] [Related]
30. Altered behavioral response to dopamine D3 receptor agonists 7-OH-DPAT and PD 128907 following repetitive amphetamine administration.
Richtand NM; Welge JA; Levant B; Logue AD; Hayes S; Pritchard LM; Geracioti TD; Coolen LM; Berger SP
Neuropsychopharmacology; 2003 Aug; 28(8):1422-32. PubMed ID: 12700693
[TBL] [Abstract][Full Text] [Related]
31. S32504, a novel naphtoxazine agonist at dopamine D3/D2 receptors: II. Actions in rodent, primate, and cellular models of antiparkinsonian activity in comparison to ropinirole.
Millan MJ; Di Cara B; Hill M; Jackson M; Joyce JN; Brotchie J; McGuire S; Crossman A; Smith L; Jenner P; Gobert A; Peglion JL; Brocco M
J Pharmacol Exp Ther; 2004 Jun; 309(3):921-35. PubMed ID: 14978195
[TBL] [Abstract][Full Text] [Related]
32. Selective D3 receptor agonist effects of (+)-PD 128907 on dialysate dopamine at low doses.
Zapata A; Witkin JM; Shippenberg TS
Neuropharmacology; 2001 Sep; 41(3):351-9. PubMed ID: 11522326
[TBL] [Abstract][Full Text] [Related]
33. Discriminative stimulus properties of S32504, a novel D3/D2 receptor agonist and antiparkinson agent, in rats: attenuation by the antipsychotics, aripiprazole, bifeprunox, N-desmethylclozapine, and by selective antagonists at dopamine D2 but not D3 receptors.
Millan MJ; Iob L; Péglion JL; Dekeyne A
Psychopharmacology (Berl); 2007 Apr; 191(3):767-82. PubMed ID: 17047933
[TBL] [Abstract][Full Text] [Related]
34. S33138 (N-[4-[2-[(3aS,9bR)-8-cyano-1,3a,4,9b-tetrahydro[1] benzopyrano[3,4-c]pyrrol-2(3H)-yl)-ethyl]phenyl-acetamide), a preferential dopamine D3 versus D2 receptor antagonist and potential antipsychotic agent: III. Actions in models of therapeutic activity and induction of side effects.
Millan MJ; Loiseau F; Dekeyne A; Gobert A; Flik G; Cremers TI; Rivet JM; Sicard D; Billiras R; Brocco M
J Pharmacol Exp Ther; 2008 Mar; 324(3):1212-26. PubMed ID: 18096759
[TBL] [Abstract][Full Text] [Related]
35. 7-OH-DPAT and PD 128907 selectively activate the D3 dopamine receptor in a novel environment.
Pritchard LM; Logue AD; Hayes S; Welge JA; Xu M; Zhang J; Berger SP; Richtand NM
Neuropsychopharmacology; 2003 Jan; 28(1):100-7. PubMed ID: 12496945
[TBL] [Abstract][Full Text] [Related]
36. Dopamine D3 receptors regulate GABAA receptor function through a phospho-dependent endocytosis mechanism in nucleus accumbens.
Chen G; Kittler JT; Moss SJ; Yan Z
J Neurosci; 2006 Mar; 26(9):2513-21. PubMed ID: 16510729
[TBL] [Abstract][Full Text] [Related]
37. Autoradiographic localisation of D3-dopamine receptors in the human brain using the selective D3-dopamine receptor agonist (+)-[3H]PD 128907.
Hall H; Halldin C; Dijkstra D; Wikström H; Wise LD; Pugsley TA; Sokoloff P; Pauli S; Farde L; Sedvall G
Psychopharmacology (Berl); 1996 Dec; 128(3):240-7. PubMed ID: 8972543
[TBL] [Abstract][Full Text] [Related]
38. Dopamine D2 receptor knock-out mice are insensitive to the hypolocomotor and hypothermic effects of dopamine D2/D3 receptor agonists.
Boulay D; Depoortere R; Perrault G; Borrelli E; Sanger DJ
Neuropharmacology; 1999 Sep; 38(9):1389-96. PubMed ID: 10471093
[TBL] [Abstract][Full Text] [Related]
39. Antagonism of the effects of (+)-PD 128907 on midbrain dopamine neurones in rat brain slices by a selective D2 receptor antagonist L-741,626.
Bowery BJ; Razzaque Z; Emms F; Patel S; Freedman S; Bristow L; Kulagowski J; Seabrook GR
Br J Pharmacol; 1996 Dec; 119(7):1491-7. PubMed ID: 8968560
[TBL] [Abstract][Full Text] [Related]
40. Biphasic effects of D3-receptor agonists, 7-OH-DPAT and PD128907, on the D1-receptor agonist-induced hyperactivity in mice.
Mori T; Murase K; Tanaka J; Ichimaru Y
Jpn J Pharmacol; 1997 Mar; 73(3):251-4. PubMed ID: 9127821
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
